CareDx, Inc. (CDNA)
18.69
-1.18
(-5.94%)
USD |
NASDAQ |
Feb 20, 15:36
CareDx EPS Diluted (Quarterly) : 0.0312 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.675M |
| Revenue (Quarterly) | 100.06M |
| Total Expenses (Quarterly) | 98.38M |
| Enterprise Value | 855.39M |
| Gross Profit Margin (Quarterly) | 68.71% |
| Profit Margin (Quarterly) | 1.67% |
| Earnings Yield | 6.38% |
| Normalized Earnings Yield | 0.9610 |